Oxeltra 30mg modified-release tablets
BNF presentation 0407020ADBLACAR within chapter Central Nervous System. Analyse prescribing behaviour, spending pressure, and high-usage pharmacies.
Product
Chemical substance
Chapter
Presentation code
0407020ADBLACAR
Usage overview
Total items and spend derived from NHS dispensing data.
Items dispensed
3,370
NHS spend (£)
£49,197.27
Recent activity
March 2025
Monitor this presentation to understand cost pressures, availability challenges, and opportunities for clinical optimisation.
Dispensing trend
Month-by-month national usage.
| Month | Items dispensed |
|---|---|
| March 2025 | 461 |
| February 2025 | 4 |
| December 2024 | 141 |
| November 2024 | 524 |
| October 2024 | 512 |
| August 2024 | 63 |
| July 2024 | 509 |
| May 2024 | 127 |
| July 2021 | 166 |
| June 2021 | 99 |
| December 2020 | 387 |
| November 2020 | 377 |
Top pharmacies dispensing this medicine
Identify providers with the highest utilisation to focus engagement and support.
| Pharmacy | Items | Region |
|---|---|---|
| Unknown pharmacy | 77 | No data available |
| Unknown pharmacy | 51 | No data available |
| Unknown pharmacy | 38 | No data available |
| Unknown pharmacy | 34 | No data available |
| Unknown pharmacy | 31 | No data available |
| Unknown pharmacy | 29 | No data available |
| Unknown pharmacy | 29 | No data available |
| Unknown pharmacy | 28 | No data available |
| Unknown pharmacy | 27 | No data available |
| Unknown pharmacy | 27 | No data available |